[HTML] cell.comFull View

[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - Cell host & …, 2021 - cell.com
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
被引用次数：420 相关文章

SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - bioRxiv, 2021 - biorxiv.org
ABSTRACT The SARS-CoV-2 Spike glycoprotein mediates virus entry and is a major target
for neutralizing antibodies. All current vaccines are based on the ancestral Spike with the …

SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal… - Cell Host and …, 2021 - lanlexperts.elsevierpure.com
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
[HTML] sciencedirect.com

[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - Cell Host & Microbe, 2021 - Elsevier
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal, K Wagh… - Cell Host & …, 2021 - ncbi.nlm.nih.gov
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
[HTML] europepmc.org

[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - 2021 - europepmc.org
ABSTRACT The SARS-CoV-2 Spike glycoprotein mediates virus entry and is a major target
for neutralizing antibodies. All current vaccines are based on the ancestral Spike with the …

[引用][C] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - Cell Host & …, 2021 - cir.nii.ac.jp
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike
vaccines | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

X Shen, H Tang, C McDanal, K Wagh… - Cell host & …, 2021 - pubmed.ncbi.nlm.nih.gov
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …

SARS-CoV-2 Variant B. 1.1. 7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines

X Shen, H Tang, C McDanal, K Wagh, WM Fischer… - papers.ssrn.com
Abstract The SARS-CoV-2 Spike glycoprotein mediates virus entry and is a major target for
neutralizing antibodies. All current vaccines are based on the ancestral Spike with the goal …

SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.

X Shen, H Tang, C McDanal, K Wagh, W Fischer… - 2021 - cabidigitallibrary.org
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …